Antifungal activity, SAR and physicochemical correlation of some thiazole-1,3,5-triazine derivatives

Journal de Mycologie Medicale

Volumn 22, Issue 2, 2012, Pages 134-141

  Singh, U P ^a   Bhat, H R ^a   Gahtori, P ^b  

^a SAM HIGGINBOTTOM UNIVERSITY OF AGRICULTURE   (India)

^b DIBRUGARH UNIVERSITY   (India)

Author keywords

1,3,5 triazine; Antifungal activity; Physicochemical property; SAR

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; THIAZOLE 1,3,5 TRIAZINE DERIVATIVE; TRIAZINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG ACTIVITY; DRUG STRUCTURE; MINIMUM FUNGICIDAL ACTIVITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHYSICAL CHEMISTRY; STRUCTURE ACTIVITY RELATION; SUBSTITUTION REACTION; TOXICITY TESTING;

ANIMALS; ANTIFUNGAL AGENTS; ARTEMISIA; ASPERGILLUS NIGER; CANDIDA ALBICANS; CANDIDA GLABRATA; CRYPTOCOCCUS NEOFORMANS; DRUG EVALUATION, PRECLINICAL; LARVA; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; MOLECULAR WEIGHT; STRUCTURE-ACTIVITY RELATIONSHIP; THIAZOLES; TRIAZINES;

ASPERGILLUS NIGER; CANDIDA ALBICANS; CANDIDA GLABRATA; DECAPODA (CRUSTACEA); FILOBASIDIELLA NEOFORMANS;

EID: 84859596863     PISSN: 11565233     EISSN: 17730449     Source Type: Journal    
DOI: 10.1016/j.mycmed.2011.12.073     Document Type: Article

References (30)

1. Ablordeppey S., Fan P., Ablordeppey J.H., Mardenborough L. Systemic antifungal agents against AIDS-related opportunistic infections: current status and emerging drugs in development. Curr Med Chem 1999, 6:1151-1195.
2. Alfonso J.A. Resistance to antibiotics: are we in the post-antibiotic era?. Arch Med Res 2005, 36:697-705.
3. Bremner J.B., Ambrus J.I., Samosorn S. Dual action-based approaches to antibacterial agents. Curr Med Chem 2007, 14:1459-1477.
4. Bryskier A. Dual β-lactam-fl{ligature}uoroquinolone compounds: a novel approach to antibacterial treatment. Exp Opin Invest Drugs 1997, 6:1479-1499.
5. Carballo J.L., Hernández-Inda Z.L., Pérez P., García-Grávalos M.D. A comparison between two brine shrimp assays to detect in vitro cytotoxicity in marine natural products. BMC Biotechnol 2002, 2:17.
6. Bioassay techniques for drug development 2001, 9-10. Harwood Academic Publishers, Amsterdam. M.I. Choudhary, W.J. Thomsen (Eds.).
7. Clark D.E. Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood-brain barrier penetration. J Pharm Sci 1999, 88:815-821.
8. Clinical and Laboratory Standards Institute (CLSI): Reference method for broth dilution antifungal susceptibility testing of filamentous fungi: approved standard. M38-A, Wayne, Pa. 2002.
9. Clinical and Laboratory Standards Institute (CLSI): Reference method for broth dilution antifungal susceptibility testing of yeasts: approved standard. M27-A2. Wayne, Pa. 2002.
10. Ertl P., Rohde B., Selzer P. Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J Med Chem 2000, 43:3714-3717.
11. Gahtori P., Das A., Bhatt H. Synthesis and antibacterial assessment of N- [4-(4-substituted phenyl)-1,3-thiazol-2-yl]-1,3,5-triazin-2-amine. Indian J Pharm Sci 2009, 7:79-82.
12. Gahtori P., Singh A., Ghosh S.K., Das A., Archana U. Synthesis of some substituted phenylthiazolyl 1,3,5-triazine derivatives. Asian J Chem 2010, 23:1189-1192.
13. Golankiewicz B., Januszczyk P., Ikeda S., Balzarini J., De Clercq E. Synthesis and antiviral activity of benzyl-substituted imidazo [1,5-a]-1,3,5-triazine (5,8-diaza-7,9-dideazapurine) derivatives. J Med Chem 1995, 38:3558-3565.
14. Hernandes M.Z., Cavalcanti S.M., Moreira D.R., de Azevedo Junior W.F., Leite A.C. Halogen atoms in the modern medicinal chemistry: hints for the drug design. Curr Drug Targets 2010, 11:303-314.
15. Holla B.S., Malini K.V., Rao B.S., Sarojini B.K., Kumari N.S. Synthesis of some new 2,4-disubstituted thiazoles as possible antibacterial and anti-inflammatory agents. Eur J Med Chem 2003, 38:313-318.
16. Huang Q., Mao J., Wan B., Wang Y., Brun R., Franzblau S.G., et al. Searching for new cures for tuberculosis: design, synthesis, and biological evaluation of 2-methylbenzothiazoles. J Med Chem 2009, 52:6757-6767.
17. Karade H.N., Acharaya B.N., Sathe M., Kaushik M.P. Design, synthesis, and antimalarial evaluation of thiazole-derived amino acids. Med Chem Res 2008, 17:19-29.
18. Katiyar S.B., Srivastava K., Puri S.K., Chauhan P.M. Synthesis of 2-[3,5-substituted pyrazol-1-yl]-4,6-trisubstituted triazine derivatives as antimalarial agents. Bioorg Med Chem Lett 2005, 15:4957-4960.
19. Li D., Calderone R. Pathogenic fungi: host interaction and emerging strategies for control 2004, 335-355. Caister Academic Press, Norfolk. G. San-Blas, R. Calderone (Eds.).
20. Li C.M., Wang Z., Lu Y., Ahn S., Narayanan R., Kearbey J.D., et al. Biological activity of 4-substituted methoxybenzoyl-aryl-thiazole: an active microtubule inhibitor. Cancer Res 2011, 71:216-224.
21. Mayhoub A.S., Khaliq M., Kuhn R.J., Cushman M. Design, synthesis, and biological evaluation of thiazoles targeting flavivirus envelope proteins. J Med Chem 2011, 54:1704-1714.
22. Pervez A., Meshram J., Tiwari V., Sheik J., Dongre R., Youssoufi M.H., et al. Pharmacophores modeling in terms of prediction of theoretical physico-chemical properties and verification by experimental correlations of novel coumarin derivatives produced via Betti's protocol. Eur J Med Chem 2010, 45:4370-4378.
23. Saczewski F., Bułakowska A. Synthesis, structure and anticancer activity of novel alkenyl-1,3,5-triazine derivatives. Eur J Med Chem 2006, 41:611-615.
24. Silver L.L. Multi-targeting by monotherapeutic antibacterials. Nat Rev Drug Discov 2007, 6:41-55.
25. Singh U.P., Singh R.K., Bhat H.R., Subhashchandra Y.P., Kumar V., Kumawat M.K., et al. Synthesis and antibacterial evaluation of series of novel tri-substituted-s-triazine derivatives. Med Chem Res 2011, 20:1603-1610.
26. Srinivas K., Srinivas U., Rao V.J., Bhanuprakash K., Kishore K.H., Murty U.S. Synthesis and antibacterial activity of 2,4,6-tri substituted s-triazines. Bioorg Med Chem Lett 2005, 15:1121-1123.
27. Sunduru N., Gupta L., Chaturvedi V., Dwivedi R., Sinha S., Chauhan P.M. Discovery of new 1,3,5-triazine scaffolds with potent activity against Mycobacterium tuberculosis H37Rv. Eur J Med Chem 2010, 45:3335-3345.
28. White T.C., Marr K., Borden R. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev 1998, 11:382-402.
29. http://www.molinspiration.com/.
30. Zacchino S., Yunes R., Cechinel Filho V., Enriz D., Kouznetsov V., Ribas J.C. Plant-derived antimycotics: current trends and future prospects 2003, 1-47. Haworth Press, New York. M. Rai, D. Mares (Eds.).